Recombinant Anti-TNFRSF8 Antibody (V3S-0522-YC1963) (CAT#: V3S-0522-YC1963)

Send Inquiry
  • fig1
    Figure 1 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in ELISA
  • fig1
    Figure 2 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in WB
  • fig1
    Figure 3 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in DB
  • fig1
    Figure 4 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in SEC-HPLC
  • fig1
    Figure 5 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in SDS-PAGE

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize TNF receptor superfamily member 8. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Immunogen Soluble CD30
Affinity KD = 1.2 nM, determined by surface plasmon resonance.
Isotype IgG, κ

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application ELISA; WB; DB; FC; Cyt; FuncS
Application Notes The antibody is recommended for detection of TNFRSF8 by FC, Cyt, FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target TNFRSF8
Alternative Name CD30; Ki-1; D1S166E
Gene ID 943
UniProt P28908
Research Area Immunology
Related Disease HD

Tested Data

ELISA

Figure 1 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in ELISA

ELISA analysis of V3S-0522-YC1963 was performed by coating with Human CD30/TNFRSF8 Protein (His Tag). Then blocked with BSA and incubated with V3S-0522-YC1963. The HRP-conjugated goat anti-human IgG as a secondary antibody (1: 8000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Lane 1: Reducing Antigen (0.1 μg)
Lane 2: Reducing Antigen (0.4 μg)
Lane 3: Reducing Antigen (0.6 μg)

Figure 1 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in ELISA

WB

Figure 2 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in WB

Western blot analysis of V3S-0522-YC1963 was performed by loading Human CD30/TNFRSF8 Protein (His Tag) in reduced condition Lane 1, Lane 2 and Lane 3 (0.1 μg, 0.3 μg and 0.6 μg respectively) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0522-YC1963 (2 μg/mL) and HRP-conjugated goat anti-human IgG as a secondary antibody (1: 6000). Chemiluminescent detection was performed.

Figure 2 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in WB

DB

Figure 3 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in DB

Dot Blot analysis of V3S-0522-YC1963 was performed by coating with Human CD30/TNFRSF8 Protein (His Tag).

V3S-0522-YC1963 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 6000)
NC: Negative control PC: Positive control

Figure 3 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in DB

SEC-HPLC

Figure 4 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in SEC-HPLC

The purity of V3S-0522-YC1963 was greater than 95% as determined by SEC-HPLC.
Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.0
Detection: UV 280 nm
Injection: 10 µl

Figure 4 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in SEC-HPLC

SDS-PAGE

Figure 5 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in SDS-PAGE

SDS-PAGE analysis of V3S-0522-YC1963 in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.

Figure 5 Anti-TNFRSF8 Monoclonal Antibody (V3S-0522-YC1963) in SDS-PAGE

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry